Skip to content

AMEXDRUG CORP

CIK 0000045621

← back to feed
Revenue (TTM)
$9M
−26.3% YoY Q2 Aug 2013
Net Income (TTM)
$308.41K
−18.5% YoY Q2 Aug 2013
EPS Diluted (TTM)
—
Q2 Aug 2013
Gross Margin
15.2%
Q2 Aug 2013
Operating Margin
5.3%
Q2 Aug 2013
Net Margin
3.4%
Q2 Aug 2013
Free Cash Flow (TTM)
−$990.4K
Q2 Aug 2013
Cash
$162.57K
Q2 Aug 2013
Total Debt
—
Q2 Aug 2013
Shares Outstanding
169.41M sh
Q2 Aug 2013

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings